FDA Approves Opdivo (Nivolumab) for Small Cell Lung Cancer
The US Food and Drug Administration had approved the immunotherapy drug Opdivo (nivolumab) to treat people with small cell lung cancer (SCLC).
Ovarian Cancer Survivor Views Each Day as a Gift
When Mercedes Mundaca was diagnosed with stage 4 ovarian cancer at age 43, her doctor told her she had 4 months to live. That was 6 years ago.
A Cancer Control Report Card and Blueprint
This first chapter in the American Cancer Society Cancer Control Blueprint sets up the steps to take in the future to lower the incidence and death rate of cancer by looking at what's led to success in the past. It's delivered by staff researcher Rebecca Siegel, MPH, scientific director of surveillance information.
Cancer Patients Want More Information From Doctors About Cost
A study led by researchers from University of Michigan has found that many cancer patients would like more help from their health care providers in addressing costs of treatment.
How Safe is Your Sunscreen?
The American Cancer Society recommends sunscreen to protect your skin, but some groups have raised concerns over ingredients found in some sunscreens.
FDA Approves Poteligeo (Mogamulizumab) for Lymphoma of the Skin
The US Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab) to treat people with some types of skin lymphoma.
The ACS Blueprint: A Vision for Reducing Deaths from Cancer
The American Cancer Society Cancer Control Blueprint—introduced by an interview with Otis W. Brawley, MD, MACP, chief medical and scientific officer of the ACS. The blueprint, says Brawley, is both a celebration of our progress against cancer and a call to action to do even better.
What Is Cancer Control?
We talk about "cancer control" all the time, but what does it really mean? How does it relate to "cancer burden?" Find out.